Self-Identification of Generic Drug Facilities, Sites, and Organizations; Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 23, 2016
April 29, 2020
0f6af607-fb4c-4df3-8f72-edf8eeb27fbe
Related Documents
Clinical Pharmacology Labeling for Human Prescription Drug and Biological Products — Content and Format
Guidance DocumentDecember 5, 2016Center for Drug Evaluation and Research
Bioanalytical Method Validation Guidance for Industry
Guidance DocumentMay 22, 2018Center for Drug Evaluation and Research
E2C(R2) Periodic Benefit-Risk Evaluation Report – Questions and Answers
Guidance DocumentJuly 19, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.